Article
Estrogen therapy fails to alter amyloid deposition in the PDAPP model of Alzheimer's disease.
Endocrinology - 1 Jun 2005
Green Pattie S, Bales Kelly, Paul Steven, Bu Guojun
Abstract excerpt
Epidemiological studies implicate estrogen deprivation as a risk factor for Alzheimer's disease and postmenopausal estrogen replacement as protective factor. One potential mechanism involves estrogen attenuation of beta-amyloid (Abeta) peptide accumulation. We examined the effect of estrogen on amyloid accumulation in female PDAPP mice, which express human amyloid precursor protein (APP) with the V717F mutation....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
